NCT03017404View on ClinicalTrials.gov

A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

July 31, 2016

Conditions

Breast Cancer

Interventions

DRUG

Doxorubicin Hydrochloride Liposome Injection

DRUG

Cyclophosphamide

DRUG

docetaxel

Trial Locations (1)

050019

Fourth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors

lead

Hebei Medical University Fourth Hospital

OTHER

NCT03017404 - A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer | Biotech Hunter | Biotech Hunter